Company Quick10K Filing
EVIO
Price-0.00 EPS-0
Shares28 P/E0
MCap-0 P/FCF0
Net Debt1 EBIT-8
TEV1 TEV/EBIT-0
TTM 2019-06-30, in MM, except price, ratios
10-Q 2020-06-30 Filed 2020-09-09
10-Q 2020-03-31 Filed 2020-09-09
10-Q 2019-12-31 Filed 2020-09-08
10-K 2019-09-30 Filed 2020-05-20
10-Q 2019-06-30 Filed 2019-11-15
10-Q 2019-03-31 Filed 2019-10-18
10-Q 2018-12-31 Filed 2019-09-30
10-K 2018-09-30 Filed 2019-08-19
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-16
10-Q 2017-12-31 Filed 2018-02-13
10-K 2017-09-30 Filed 2018-01-17
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-22
10-Q 2016-12-31 Filed 2017-04-19
10-K 2016-09-30 Filed 2017-02-24
10-Q 2016-06-30 Filed 2016-09-15
10-Q 2016-03-31 Filed 2016-06-03
10-Q 2015-12-31 Filed 2016-02-29
10-K 2015-09-30 Filed 2016-02-02
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-14
10-Q 2014-12-31 Filed 2015-02-12
8-K 2021-02-04 Enter Agreement, Off-BS Arrangement, Sale of Shares, Regulation FD
8-K 2021-02-02 M&A, Regulation FD
8-K 2020-12-31 Officers
8-K 2020-11-17
8-K 2020-09-08
8-K 2020-07-06
8-K 2020-06-28
8-K 2020-05-15
8-K 2020-01-15
8-K 2019-11-20
8-K 2019-08-27
8-K 2019-06-20
8-K 2019-05-20
8-K 2019-05-01
8-K 2019-03-20
8-K 2019-02-13
8-K 2019-01-17
8-K 2018-12-31
8-K 2018-11-19
8-K 2018-10-15
8-K 2018-08-27
8-K 2018-08-15
8-K 2018-06-27
8-K 2018-06-22
8-K 2018-05-02
8-K 2018-04-29
8-K 2018-04-18
8-K 2018-04-16
8-K 2018-02-06
8-K 2018-01-30
8-K 2018-01-01
8-K 2017-12-27

EVIO 10Q Quarterly Report

Part I &Mdash; Financial Information
Note 1 - Organization, Basis of Presentation and Significant Accounting Policies
Note 2 - Going Concern
Note 3 - Fair Value of Financial Instruments
Note 4 - Leases
Note 5 - Intangible Assets
Note 6 - Concentration of Credit Risk
Note 7 - Property and Equipment
Note 8 - Related Party Transactions
Note 9 - Stockholders' Equity
Note 10 - Loans Payable
Note 11 - Convertible Notes Payable
Note 12 - Convertible Debentures
Note 13 - Derivative Liability
Note 14 - Stock Options and Warrants
Note 15 - Subsequent Events
Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3 - Quantitative and Qualitative Disclosures About Market Risk
Item 4 - Controls and Procedures
Part II &Mdash; Other Information
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sale of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
EX-31.1 ex31-1.htm
EX-31.2 ex31-2.htm
EX-32.1 ex32-1.htm
EX-32.2 ex32-2.htm

EVIO Earnings 2020-06-30

Balance SheetIncome StatementCash Flow
20151061-22013201520172020
Assets, Equity
3.21.80.4-1.1-2.5-3.92013201520172020
Rev, G Profit, Net Income
10.07.65.22.80.4-2.02013201520172020
Ops, Inv, Fin

10-Q 1 form10q.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2020

 

or

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to __________.

 

Commission File Number: 000-12350

 

EVIO, INC.

(Exact name of registrant as specified in its charter)

 

Colorado   47-1890509
(State of Incorporation)  

(I.R.S. Employer

Identification No.)

     

2654 W. Horizon Ridge Pkwy, Suite B5-208

Henderson, NV

89052

(Address of principal executive offices)   (Zip Code)

 

(702) 748-9944

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [  ] Non-accelerated filer [  ]
Accelerated filer [  ] Smaller reporting company [X]
    Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]

 

As of September 4, 2020 there were 89,142,473 shares of common stock outstanding.

 

 

 

 

 

 

EVIO, INC.

FORM 10-Q

QUARTERLY PERIOD ENDED JUNE 30, 2020

 

TABLE OF CONTENTS

 

PART I — FINANCIAL INFORMATION  
     
Item 1. Consolidated Financial Statements (Unaudited)  
  Consolidated Balance Sheets as of June 30, 2020 (Unaudited) and September 30, 2019 3
  Consolidated Statements of Operations for the Three Months Ended June 30, 2020, and 2019 (Unaudited) 4
  Consolidated Statements of Cash Flows for the Three Months Ended June 30, 2020, and 2019 (Unaudited) 5
  Consolidated Statements of Stockholders Equity for the Three Months June 30, 2020, and 2019 (Unaudited) 6
  Notes to Unaudited Consolidated Financial Statements 8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 29
  Critical Accounting Policies and Estimates 30
  Results of Operations 30
  Liquidity and Capital Resources 31
Item 3. Quantitative and Qualitative Disclosures About Market Risk 32
Item 4. Control and Procedures 32
     
PART II — OTHER INFORMATION  
     
Item 1. Legal Proceedings 32
Item 1A. Risk Factors 33
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 33
Item 3. Defaults Upon Senior Securities 33
Item 4. Mine Safety Disclosures 33
Item 5. Other Information 33
Item 6. Exhibits 33

 

2

 

 

PART I — FINANCIAL INFORMATION

 

EVIO, INC.

Consolidated Balance Sheets (Unaudited)

 

   June 30,   September 30, 
   2020   2019 
         
ASSETS          
Current assets:          
Cash and cash equivalents  $71,396   $110,325 
Accounts receivable, net   110,786    133,022 
Prepaid expenses   105,039    190,460 
Other current assets   44,766    9,689 
Note receivable, current portion   538,904    538,904 
Total current assets   870,891    982,400 
Right of use assets   1,832,856    2,543,976 
Capital assets, net   1,116,734    1,383,828 
Land   212,550    212,550 
Property and equipment, net   2,643,460    3,080,426 
Security deposits   176,650    178,918 
Prepaid expenses, net   -    4,061 
Total assets  $6,853,141   $8,386,159 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable and accrued liabilities  $4,443,243   $3,811,237 
Client deposits   42,022    108,418 
Interest payable   1,693,136    1,387,642 
Capital lease obligation, current   902,894    957,673 
Derivative liability   2,134,395    2,545,735 
Convertible notes payable, net of discounts   3,721,712    3,695,484 
Loans payable, net of discounts, current   788,006    762,476 
Total current liabilities   13,725,408    13,268,665 
Convertible debentures, net of loan discounts   3,694,043    1,734,890 
Lease liabilities   1,886,722    2,594,726 
Capital lease obligation, net   121,729    381,786 
Loans payable, net   702,578    657,603 
Loans payable, related party, net   1,417,793    1,560,849 
Total liabilities   21,548,273    20,198,519 
           
Commitments and contingencies   -    - 
           
Stockholders’ Equity:          
Series B convertible preferred stock, $0.0001 par value. 5,000,000 authorized; 5,000,000 shares issued and outstanding at June 30, 2020 and September 30, 2019, respectively   500    500 
Series C convertible preferred stock, $0.0001 par value. 500,000 authorized; 500,000 shares issued and outstanding at June 30, 2020 and September 30, 2019, respectively   50    50 
Series D convertible preferred stock, $0.0001 par value. 1,000,000 authorized; 349,500 and 349,500 shares issued and outstanding at June 30, 2020 and September 30, 2019, respectively   34    34 
Common stock, $0.0001 par value. 1,000,000,000 authorized; 94,217,473 and 29,314,419 shares issued and outstanding at June 30, 2020 and September 30, 2019, respectively   9,422    2,931 
Stock subscriptions receivable   -    - 
Additional paid-in capital   30,001,524    26,498,076 
Retained earnings (accumulated deficit)   (44,391,942)   (37,775,183)
Accumulated other comprehensive income   (328,036)   (353,090)
Total stockholders’ equity   (14,708,448)   (11,626,682)
Noncontrolling interest   13,317    (185,678)
Total equity   (14,695,131)   (11,812,360)
Total liabilities and equity  $6,853,142   $8,386,159 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

3

 

 

EVIO, INC.

Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

 

   Three Months Ended
June 30,
   Three Months Ended
June 30,
 
   2020   2019 
         
Revenues          
Testing revenue  $603,192   $1,098,310 
Consulting revenue   -    3,000 
Total revenues   603,192    1,101,310 
           
Cost of revenue          
Testing services   455,497    823,540 
Consulting services   (1,824)   - 
Depreciation and amortization   289,594    289,523 
Total cost of revenue   743,267    1,113,063 
           
Gross margin   (140,075)   (11,753)
           
Operating expenses:          
Selling, general and administrative   147,873    1,504,539 
Depreciation and amortization   17,907    62,291 
Total operating expenses   165,780    1,566,830 
           
Income (loss) from operations   (305,855)   (1,578,583)
           
Other income (expense)          
Interest income (expense), net   (960,485)   (592,089)
Other income (expense)   (359,805)   (178,549)
Gain (loss) on settlement of debt   -    - 
Impairment charge   -    - 
Gain (loss) on change in fair market value of derivative liabilities   224,783    981,421 
Total other income (expense)   (1,095,507)   210,783 
Income (loss) before income taxes   (1,401,362)   (1,367,800)
           
Provision for income taxes (benefit)   -    2,735 
           
Net income (loss)   (1,401,362)   (1,370,535)
Net income (loss) attributable to noncontrolling interest   (51,954)   (49,257)
Net income (loss) attributable to EVIO, Inc. shareholders  $(1,349,408)  $(1,321,278)
           
Basic and diluted earnings (loss) per common share  $(0.03)  $(0.05)
           
Weighted-average number of common shares outstanding:          
Basic and diluted   49,561,707    25,366,021 
           
Comprehensive loss:          
Net income (loss)  $(1,401,362)  $(1,370,535)
Foreign currency translation adjustment   26,282    64,261 
Comprehensive income (loss)  $(1,375,080)  $(1,306,274)

 

The accompanying notes are an integral part of the consolidated financial statements.

 

4

 

 

EVIO, INC.

Consolidated Statements of Cash Flows (Unaudited)

 

   Nine Months Ended
June 30,
   Nine Months Ended
June 30,
 
   2020   2019 
Cash flows from operating activities of continuing operations:        
Net income (loss)  $(6,688,377)  $(7,842,302)
Adjustments to reconcile net loss to cash used in operating activities:          
Amortization of debt discount   2,875,551    2,241,279 
Common stock issued in exchange for fees and services   333,830    342,910 
Default penalties and other covenant adjustments on convertible debentures   62,500      
Deferred taxes   -    - 
Depreciation and amortization   819,099    1,080,100 
Impairment of goodwill and long lived assets   375,614    - 
Loss on disposal of assets   2,979    64,095 
Loss on settlement of accounts payable   -    - 
Loss on settlement of debt   10,000    - 
Provision for doubtful accounts   25,873    49,835 
Provision for excess or obsolete inventory   -    - 
Stock based compensation   903,683    576,124 
Unrealized (gain) loss on derivative liability   (450,580)   (424,774)
Changes in operating assets and liabilities:          
Accounts receivable   (7,944)   (144,052)
Prepaid expenses   89,483    (74,605)
Other current assets   (35,115)   89,842 
Security deposits   1,775    (35,646)
Operating lease right of use assets   3,116    49,541 
Other assets   -    - 
Accounts payable and accrued liabilities   471,812    1,281,150 
Customer deposits and deferred revenues   (66,397)   (206,113)
Deposits, related party   -    - 
Income taxes payable   -    - 
Interest payable   515,321    595,752 
Net cash provided by (used in) operating activities   (757,777)   (2,356,864)
           
Cash flows from investing activities:          
Cash consideration for acquisition of business   -    - 
Notes receivable   -    761,096 
Purchase of fixed assets   (39,206)   (853,644)
Purchase of intangible assets   -    - 
Net cash provided by (used in) financing activities   (39,206)   (92,548)
           
Cash flows from financing activities:          
Proceeds from issuance of preferred stock, net of issuance costs   -    - 
Proceeds from issuance of common stock, net of issuance costs   -    592,000 
Proceeds from exercise of common stock purchase warrants, net of issuance costs   -    - 
Proceeds from issuance of convertible debentures   -    374,000 
Proceeds from issuance of convertible notes, net of issuance costs   1,055,102    1,078,732 
Proceeds from loans payable   -    2,718 
Proceeds from related party advances   80,431    144,193 
Repayments of capital leases   (294,727)   274,553 
Repayments of convertible debentures   -    - 
Repayments of loans payable   (34,920)   (30,476)
Repayments of related party loans payable   (71,063)   (11,906)
Net cash provided by (used in) financing activities   734,823    2,423,814 
           
Effect of exchange rates on cash and cash equivalents   23,232    4,927 
Net increase (decrease) in cash and cash equivalents   (38,928)   (20,671)
Cash and cash equivalents at beginning of period   110,325    81,735 
Cash and cash equivalents at end of period  $71,397   $61,064 
           
Supplemental disclosure of cash flow information:          
Cash paid for interest  $-   $- 
Cash paid for income taxes  $-   $- 
           
Supplemental disclosure of non-cash investing and financing activities:          
Conversion of convertible note and accrued interest into common stock  $1,828,842   $708,089 
Reclassification of derivative liability to additional paid in capital  $-   $- 
Settlement of account payable for common stock  $6,000   $- 
Common stock issued for settlement of note payable  $-   $15,000 
Common stock issued for settlement of related party note payable  $-   $- 
Common stock issued for subscription receivable  $-   $- 
Conversion of Series D Preferred stock to common stock  $-   $364,462 
Debt discount recorded on convertible notes and debentures payable upon initial measurement of derivative liability  $39,241   $846,985 
Debt discounts recorded for beneficial conversion features on convertible debentures and notes payable  $260,083   $- 
Debt discounts recorded for original issue discounts on convertible debentures  $-      
Vehicles financed through notes payable  $105,424   $- 
Equipment financed through capital leases  $-   $322,383 
Issuance of convertible notes payable and other obligations in connection with the acquisition of a business  $-   $- 
Sale and assumption of note payable and accrued interest  $-   $556,658 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

5

 

 

EVIO, INC.

Consolidated Statements of Changes in Stockholders’ Equity (Unaudited)

 

                                               Accumulated             
   Series B    Series C    Series D           Stock   Additional       Other   Total         
   Preferred Stock   Preferred Stock   Preferred Stock   Common Stock   Subscriptions   Paid-in   Retained   Comprehensive   Stockholders’   Noncontrolling   Total 
   Shares   Value   Shares   Value   Shares   Value   Shares   Value   Receivable   Capital   Earnings   Income   Equity   Interest   Equity 
                                                                            
Balance, March 31, 2019   5,000,000   $500    500,000   $50    552,500   $55    16,068,505   $1,606   $-   $12,925,709   $(10,258,765)  $-   $2,669,155   $545,328   $3,214,483 
                                                                            
Net income (loss)   -    -    -    -    -    -    -    -    -    -    (3,199,989)   -    (3,199,989)   (257,101)   (3,457,090)
Change in foreign currency translation   -    -    -    -    -    -    -    -    -    -    -    (317,132)   (317,132)   -    (317,132)
Issuance of common stock in connection with the conversion of                                                                           
Series D preferred stock   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with sales made under                                                                           
private offerings   -    -    -    -    -    -    1,291,392    129    -    1,533,372    -    -    1,533,501    -    1,533,501 
Issuance of common stock in connection with the exercise of                                                                           
common stock purchase warrants   -    -    -    -    -    -    13,333    1    -    7,998    -    -    7,999    -    7,999 
Issuance of common stock as compensation to employees, officers                                                                           
and/or directors   -    -    -    -    -    -    140,000    14    -    272,548    -    -    272,562    -    272,562 
Issuance of common stock in exchange for consulting, professional                                                                           
and other services provided   -    -    -    -    -    -    15,000    2    -    10,805    -    -    10,807    -    10,807 
Issuance of common stock in satisfaction of debt issuances costs   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the settlement                                                                           
of accounts payable   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the settlement                                                                           
of notes payable   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the conversion                                                                           
of loans payable   -    -    -    -    -    -    2,121,233    212    -    1,493,573    -    -    1,493,785    -    1,493,785 
Issuance of common stock in connection with the conversion                                                                           
of debentures   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the conversion                                                                           
of related party notes payable   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the conversion                                                                           
of interest payable   -    -    -    -    -    -    70,440    7    -    48,096    -    -    48,103    -    48,103 
Common stock options issued under employee equity incentive plan   -    -    -    -    -    -    -    -    -    321,898    -    -    321,898    -    321,898 
Reclassifcation of derivative liability to additional paid-in capital   -    -    -    -    -    -    -    -    -    1,459,658    -    -    1,459,658    -    1,459,658 
Recognition of beneficial conversion features related to                                                                           
convertible debt instruments   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Acquisition of equity interests in subsidiaries   -    -    -    -    -    -    -    -    -    -    -    -    -    1,962,095    1,962,095 
                                                                            
Balance, June 30, 2019   5,000,000   $500    500,000   $50    552,500   $55    19,719,903   $1,971   $-   $18,073,657   $(13,458,754)  $(317,132)  $4,300,347   $2,250,322   $6,550,669 

 

                                               Accumulated             
                                   Additional   Additional       Other   Total         
   Preferred Stock   Preferred Stock   Preferred Stock   Common Stock   Paid-in   Paid-in   Retained   Comprehensive   Stockholders’   Noncontrolling   Total 
   Shares   Value   Shares   Value   Shares   Value   Shares   Value   Capital   Capital   Earnings   Income   Equity   Interest   Equity 
                                                                            
Balance, March 31, 2020   5,000,000   $500    500,000   $50    339,500   $34    78,717,473   $7,872   $-   $29,695,137   $(43,042,534)  $(348,167)  $(13,687,108)  $(205,342)  $(13,892,450)
                                                                            
Net income (loss)   -    -    -    -    -    -    -    -    -    -    (1,349,408)   -    (1,349,408)   (51,954)   (1,401,362)
Change in foreign currency translation   -    -    -    -    -    -    -    -    -    -    -    20,131    20,131    -    20,131 
Issuance of common stock in connection with the conversion of                                                                           
Series D preferred stock   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with sales made under                                                                           
private offerings   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with stock subscriptions                                                                           
received under private offerings   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the exercise of                                                                           
common stock purchase warrants   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock as compensation to employees, officers                                                                           
and/or directors   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in exchange for consulting, professional                                                                           
and other services provided   -    -    -    -    -    -    500,000    50    -    4,950    -    -    5,000    -    5,000 
Issuance of common stock in satisfaction of debt issuances costs   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the settlement                                                                           
of accounts payable   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the settlement                                                                           
of notes payable   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the conversion                                                                           
of loans payable   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the conversion                                                                           
of debentures   -    -    -    -    -    -    10,000,000    1,000    -    99,000    -    -    100,000    -    100,000 
Issuance of common stock in connection with the conversion                                                                           
of related party notes payable   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the conversion                                                                           
of interest payable   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock purchase warrants in satisfaction of                                                                           
debt issuances costs   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Reclassifcation of derivative liability to additional paid-in capital   -    -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Recognition of beneficial conversion features related to                                                                           
convertible debt instruments   -    -    -    -    -    -    -    -    -    84,763    -    -    84,763    -    84,763 
Stock based compensation related to employee stock options   -    -    -    -    -    -    -    -    -    13,173    -    -    13,173    -    13,173 
Acquisition of equity interests in subsidiaries   -    -    -    -    -    -    5,000,000    500    -    104,500    -    -    105,000    270,614    375,614 
                                                                            
Balance, June 30, 2020   5,000,000   $500    500,000   $50    339,500   $34    94,217,473   $9,422   $-   $30,001,523   $(44,391,942)  $(328,036)  $(14,708,449)  $13,318   $(14,695,131)

 

The accompanying notes are an integral part of the consolidated financial statements.

 

6

 

 

EVIO, INC.

Consolidated Statements of Changes in Stockholders’ Equity (Unaudited)

 

                                           Accumulated             
   Series B   Series C   Series D           Additional       Other   Total         
   Preferred Stock   Preferred Stock   Preferred Stock   Common Stock   Paid-in   Retained   Comprehensive   Stockholders’   Noncontrolling   Total 
   Shares   Value   Shares   Value   Shares   Value   Shares   Value   Capital   Earnings   Income   Equity   Interest   Equity 
                                                                       
Balance, September 30, 2018   5,000,000   $500    500,000   $50    552,500   $55    23,255,411   $2,326   $21,495,621   $(19,226,462)  $(263,985)  $2,008,105   $1,934,634   $3,942,739 
                                                                       
Net income (loss)   -    -    -    -    -    -    -    -    -    (18,548,721)   -    (18,548,721)   (2,120,312)   (20,669,033)
Change in foreign currency translation   -    -    -    -    -    -    -    -    -    -    (89,105)   (89,105)   -    (89,105)
Issuance of common stock in connection with the conversion of                                                                      
Series D preferred stock   -    -    -    -    (213,000)   (21)   532,500    53    (32)   -    -    -    -    - 
Issuance of common stock in connection with sales made under                                                                      
private offerings   -    -    -    -    -    -    1,415,000    141    591,859    -    -    592,000    -    592,000 
Issuance of common stock in connection with stock subscriptions                                                                      
received under private offerings   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the exercise of                                                                      
common stock purchase warrants   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock as compensation to employees, officers                                                                      
and/or directors   -    -    -    -    -    -    287,500    29    397,691    -    -    397,720    -    397,720 
Issuance of common stock in exchange for consulting, professional                                                                      
and other services provided   -    -    -    -    -    -    1,038,017    104    331,047    -    -    331,151    -    331,151 
Issuance of common stock in satisfaction of debt issuances costs   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the settlement                                                                      
of accounts payable   -    -    -    -    -    -    31,579    3    14,997    -    -    15,000    -    15,000 
Issuance of common stock in connection with the settlement                                                                      
of notes payable   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the conversion                                                                      
of loans payable   -    -    -    -    -    -    2,054,887    205    686,995    -    -    687,200    -    687,200 
Issuance of common stock in connection with the conversion                                                                      
of debentures   -    -    -    -    -    -    669,362    67    387,933    -    -    388,000    -    388,000 
Issuance of common stock in connection with the conversion                                                                      
of related party notes payable   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the conversion                                                                      
of interest payable   -    -    -    -    -    -    10,163    1    25,109    -    -    25,110    -    25,110 
Issuance of common stock purchase warrants in satisfaction of                                                                      
debt issuances costs   -    -    -    -    -    -    20,000    2    11,758    -    -    11,760    -    11,760 
Reclassification of derivative liability to additional paid-in capital   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Recognition of beneficial conversion features related to                                                                      
convertible debt instruments   -    -    -    -    -    -    -    -    1,844,834    -    -    1,844,834    -    1,844,834 
Stock based compensation related to employee stock options   -    -    -    -    -    -    -    -    710,264    -    -    710,264    -    710,264 
Acquisition of equity interests in subsidiaries   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
                                                                       
Balance, September 30, 2019   5,000,000   $500    500,000   $50    339,500   $34    29,314,419   $2,931   $26,498,076   $(37,775,183)  $(353,090)  $(11,626,682)  $(185,678)  $(11,812,360)
                                                                       
Net income (loss)   -    -    -    -    -    -    -    -    -    (6,616,759)   -    (6,616,759)   (71,618)   (6,688,377)
Change in foreign currency translation   -    -    -    -    -    -    -    -    -    -    25,054    25,054    -    25,054 
Issuance of common stock in connection with the conversion of                                                                      
Series D preferred stock   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with sales made under                                                                      
private offerings   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with stock subscriptions                                                                      
received under private offerings   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the exercise of                                                                      
common stock purchase warrants   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock as compensation to employees, officers                                                                      
and/or directors   -    -    -    -    -    -    7,453,538    745    742,367    -    -    743,112    -    743,112 
Issuance of common stock in exchange for consulting, professional                                                                      
and other services provided   -    -    -    -    -    -    5,775,670    578    333,252    -    -    333,830    -    333,830 
Issuance of common stock in satisfaction of debt default penalties   -    -    -    -    -    -    2,285,449    229    62,271    -    -    62,500    -    62,500 
Issuance of common stock in connection with the settlement                                                                      
of accounts payable   -    -    -    -    -    -    26,666    3    5,997    -    -    6,000    -    6,000 
Issuance of common stock in connection with the settlement                                                                      
of a legal matter   -    -    -    -    -    -    144,928    14    9,986    -    -    10,000    -    10,000 
Issuance of common stock in connection with the settlement                                                                      
of notes payable   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the conversion                                                                      
of loans payable   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the conversion                                                                      
of debentures   -    -    -    -    -    -    39,606,438    3,961    1,615,424    -    -    1,619,385    -    1,619,385 
Issuance of common stock in connection with the conversion                                                                      
of related party notes payable   -    -    -    -    -    -    -    -    -    -    -    -    -    - 
Issuance of common stock in connection with the conversion                                                                      
of interest payable   -    -    -    -    -    -    4,610,365    461